Galderma Phase III Data Published in the New England Journal of Medicine: Full OLYMPIA 2 Trial Results Demonstrate Nemolizumab’s Rapid Onset of Action in Prurigo Nodularis Patients
Pharmaceutical Daily,
The phase III OLYMPIA 2 trial in patients with prurigo nodularis met all primary and key secondary endpoints, showing…